Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CD200 contributors: mct - updated : 30-08-2014
HGNC name CD200 antigen
HGNC id 7203
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in renal carcinoma, head and neck carcinoma, testicular cancer, malignant mesothelioma, colon carcinoma, MGUS/smoldering myeloma, and in chronic lymphocytic leukemia
tumoral     --over  
similarly overexpressed in human melanoma cell lines and primary tumors (Petermann 2007)
constitutional     --over  
enhanced expression of CD200 and CD200R in the trophoblast, leading to an upregulation of the immune response during the first trimester of pregnancy
tumoral     --over  
in vascular endothelium surrounding cutaneous squamous cell carcinoma
constitutional     --other  
aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity
Susceptibility
Variant & Polymorphism
Candidate gene CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia (all B-CLL cells were CD200+ both in lymph nodes and in BM while all MCL cells were negative) (Palumbo 2009)
Marker
  • immunohistochemical expression of CD200 is a useful marker for the diagnosis and follow-up of plasma cell myeloma (PCM)
  • Therapy target
    SystemTypeDisorderPubmed
    cancerskin 
    anti-CD200 neutralizing antibody alone or in combination with SMO antagonists might be beneficial in the treatment of inoperable and metastatic basal cell carcinoma
    cancer  
    being a potential therapeutic target and prognostic factor for a large array of malignancies
    cancerskin 
    CD200 and CD200R1 are potential therapeutic target for metastatic melanoma
    neurologyneurodegenerativeParkinson/dementia Parkinsonism
    it is very promising to regulate microglia activation in Parkinson disease via targeting CD200-CD200R1 signaling pathways
    ANIMAL & CELL MODELS
  • Cd200-deficient mice express an inflammatory phenotype exhibiting increased macrophage or microglial activation in models of arthritis, encephalitis, and uveoretinitis